Acquisition of EndoChoice

Boston Scientific Corporation

The firm obtained antitrust clearance for Boston Scientific Corporation’s US$210 million acquisition of EndoChoice. This transaction allowed the company to provide physicians more comprehensive solutions to help assess, diagnose and treat patients with GI conditions. The team was able to get unconditional clearance for the transaction after an FTC investigation and review by Spanish authorities.

Email Disclaimer